Allergan, Novartis sign NASH clinical trials pact

19th April 2017 Uncategorised 0

Allergan is expanding its research and development programme on non-alcoholic steatohepatitis (NASH) through a collaboration with Novartis that will test a new combination therapy approach for the condition.

More: Allergan, Novartis sign NASH clinical trials pact
Source: News